Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
6,407 INR | -10.19% | -14.19% | +21.18% |
May. 10 | Neuland Laboratories' Consolidated Profit Declines in Fiscal Q4 | MT |
May. 10 | Neuland Laboratories Limited Recommends Final Dividend for the Financial Year 2023-24 | CI |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+21.18% | 1.1B | |
+30.38% | 684B | |
+28.79% | 568B | |
-4.36% | 361B | |
+19.30% | 329B | |
+3.73% | 284B | |
+17.17% | 240B | |
+9.17% | 208B | |
-7.98% | 200B | |
+7.68% | 166B |
- Stock Market
- Equities
- NEULANDLAB Stock
- News Neuland Laboratories Limited
- Transcript : Neuland Laboratories Limited, Q1 2023 Earnings Call, Aug 03, 2022